The University of Alabama at Birmingham Clinical Research Unit (CRU) — Birmingham, Alabama

The University of Alabama at Birmingham Clinical Research Unit (CRU) is a clinical research site located in Birmingham, Alabama, United States 35249.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

The University of Alabama at Birmingham Clinical Research Unit (CRU) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ.

Sponsors: enGene, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Alabama at Birmingham Clinical Research Unit (CRU)?

The University of Alabama at Birmingham Clinical Research Unit (CRU) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Alabama at Birmingham Clinical Research Unit (CRU) conducted?

The University of Alabama at Birmingham Clinical Research Unit (CRU) has 1 clinical trials on record, with 1 currently active. Their work covers Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ.

Is The University of Alabama at Birmingham Clinical Research Unit (CRU) accredited by Crixeo Health?

The University of Alabama at Birmingham Clinical Research Unit (CRU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Alabama at Birmingham Clinical Research Unit (CRU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.